Featured Videos |view more
Video
Transoral Robotic Surgery To Treat Head and Neck Cancer
Terry Day, M.D., a head and neck surgeon in the Head and Neck Tumor Center at MUSC Health and Hollings Cancer Center, discusses the benefits of treating HPV-associated throat cancer with transoral robotic surgery (TORS).
Video
Hyperthermic Intraperitoneal Chemotherapy for Abdominal Cancers
MUSC surgeon Ramsay Camp, M.D., discusses HIPEC for patients with cancer within the peritoneum, which is hard to treat with intravenous chemotherapy.
Video
Endoscopic Endonasal Resection of Pituitary Tumors
Alexander Vandergrift, M.D., a neurosurgeon at MUSC, describes removing a nonfunctioning pituitary tumor from a patient through endonasal resection using an endoscope.
Video
Limb Salvage Surgery for Pediatric Bone Sarcoma
MUSC is one of a few centers in the country that offers advanced skeletal reconstruction and limb salvage surgery for pediatric bone sarcomas.
Video
Awake Craniotomy and Tumor Resection
Abhay Varma, M.D., MUSC Health neurosurgeon at the Hollings Cancer Center, discusses the awake craniotomy and tumor resection procedure.
Video
Gamma Knife Surgery for Brain Tumors
Gamma Knife Radiosurgery is a service offered by MUSC for treatment of brain tumors, pain syndromes, arteriovenous malformations, epilepsy, and psychiatric disorders.
Featured Articles and Documents |view more
News
New technologies at MUSC are poised to detect and diagnose lung cancer earlier and less invasively.
News
CAR-T therapy at MUSC Health offers high-octane hope for previously incurable blood cancers
News
Breaking Through the Barricade
HIPEC gives physicians opportunity to treat hard-to-reach cancers in the abdomen
News
3D technology gives head and neck cancer patients a chance for the quality of life they had before their diagnosis
News
MUSC Researchers Aim to Link the Microbiome to Health and Disease
To ensure its clinicians and researchers can help create new microbiome-based therapies, MUSC is ramping up its microbiome infrastructure, providing support in sequencing the microbiota and in analyzing the resulting datasets.
The Hollings Cancer Center at the Medical University of South Carolina is a National Cancer Institute-designated cancer center and the largest academic-based cancer research program in South Carolina. The cancer center comprises more than 120 faculty cancer scientists with an annual research funding portfolio of $44 million and a dedication to reducing the cancer burden in South Carolina. Hollings offers state-of-the-art diagnostic capabilities, therapies and surgical techniques within multidisciplinary clinics that include surgeons, medical oncologists, radiation therapists, radiologists, pathologists, psychologists and other specialists equipped for the full range of cancer care, including more than 200 clinical trials.
